GMDA News and Press, Gamida Cell Ltd. From 11/16/21

Image source: The Motley Fool. Gamida Cell Ltd. (NASDAQ: GMDA) Q3 2021 Earnings Call Nov 15, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Gamida Cell Ltd. (GMDA) Q3 2021 Earnings Call Transcript

Gamida Cell Ltd (GMDA) Q3 2021 Earnings Conference Call November 15, 2021, 08:00 AM ET Company Participants Joshua Hamermesh - Chief Business Officer Julian Adams - CEO & Director Ronit Simantov - Chief Medical Officer Michele Korfin - Chief Operating & Chief Commercial Officer Shai L...

Gamida Cell (NASDAQ:GMDA): Q3 GAAP EPS of -$0.33 beats by $0.14. Cash and cash equivalents of $120.8M Press Release For further details see: Gamida Cell EPS beats by $0.14

New data being presented at American Society of Hematology (ASH) Annual Meeting demonstrating GDA-201 overall survival rate of 78% at two years with a median duration of response of 16 months and long-term clinical benefit of omidubicel with long-lasting hematopoietic recovery ...

ACM, ACRX, ADN, AMPY, AVPT, AYRO, BCLI, BFLY, CLSN, OTCQB:CVSI, FREY, GMDA, GOED, KALA, MICT, OEG, ONDS, OTLY, PLX, PTN, RAIL, SOHU, TLS, TRVN, TSN, VBLT For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Monday's open

- Gamida Cell conducted pre-BLA meeting for omidubicel with FDA - FDA requested revised analysis of manufacturing data generated at Gamida Cell’s commercial manufacturing facility - BLA submission expected in the first half of 2022 Gamida Cell Ltd. ...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for cancer and other serious diseases, today announced data evaluating the mechanism of action of nicotinamide (NAM)-enabled NK cells, demonstrating enhanced homing, cytotoxicity and tumor reduction...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that the company will host a conference call and live audio webcast on Monday, November 15, 2021, at 8:00 a.m. ET to review its third quarte...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for cancer and other serious diseases, today announced four presentations at the 63 rd American Society of Hematology (ASH) Annual Meeting, which is being held in Atlanta, Georgia or virtually f...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for cancer and other serious diseases, today announced that Aviad Pato, Ph.D., Head of Immunology Research, presented data on two nicotinamide (NAM)-enabled NK cell therapies, GDA-501 and GDA-301, a...